Cervical Cancer Diagnostic Market Report

Cervical Cancer Diagnostic Market Analysis By Test Type (Pap Testing Or Cytology Testing, HPV Testing, Colposcopy, Cervical Biopsies, Cystoscopy) And Segment Forecasts To 2024

  • Published Date: Sep, 2016
  • Base Year for Estimate: 2015
  • Report ID: GVR-1-68038-127-6
  • Format: Electronic (PDF)
  • Historical Data: 2013-2015
  • Number of Pages: 100

Table of Contents

Chapter 1 Executive Summary
Chapter 2 Market Snapshot
Chapter 3 Market Variables, Trends & Scope
                   3.1 Market Segmentation & Scope
                      3.1.1 Market driver analysis
                            3.1.1.1 Growing incidence of cervical cancer in middle-aged women
                            3.1.1.2 Increasing number of awareness programs for cervical cancer screening
                            3.1.1.3 Technological advancement
                      3.1.2 Market restraint analysis
                            3.1.2.1 Changes in regulatory guidelines for cervical cancer screening
                   3.2 Penetration & Growth Prospect Mapping
                   3.3 Cervical cancer diagnostic market - SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
                   3.4 Industry Analysis - Porter’s
Chapter 4 Market Categorization 1: Test Type Estimates & Trend Analysis
                   4.1 Cervical cancer diagnostic market: Test Type Movement Analysis
                   4.2 Pap Testing
                      4.2.1 Pap testing market estimates and forecasts, 2013 - 2024 (USD Billion)
                   4.3 HPV Testing
                      4.3.1 HPV testing estimates and forecasts, 2013 - 2024 (USD Billion)
                   4.4 Cervical Biopsies
                      4.4.1 Cervical biopsies market estimates and forecasts, 2013 - 2024 (USD Billion)
                   4.5 Cystoscopy
                      4.5.1 Cystoscopy market estimates and forecasts, 2013 - 2024 (USD Billion)
Chapter 5 Market Categorization 2: Regional Estimates & Trend Analysis
                   5.1 Cervical cancer diagnostic market Share by Region, 2013 & 2024
                   5.2 North America
                      5.2.1 North America cervical cancer diagnostic market estimates and forecasts, by test type 2013-2024 (USD Billion)
                      5.2.3 U.S.
                            5.2.3.1 U.S. cervical cancer diagnostic market estimates and forecasts, by test type 2013 - 2024 (USD Billion)
                      5.2.4 Canada
                            5.2.4.1 Canada cervical cancer diagnostic market estimates and forecasts, by test type 2013 - 2024 (USD Billion)
                   5.3 Europe
                      5.3.1 Europe cervical cancer diagnostic market estimates and forecasts, by test type 2013 - 2024 (USD Billion)
                      5.3.2 Germany
                            5.3.2.1 Germany cervical cancer diagnostic market estimates and forecasts, by test type 2013 - 2024 (USD Billion)
                      5.3.3 UK
                            5.3.3.1 UK cervical cancer diagnostic market estimates and forecasts, by test type 2013 - 2024 (USD Billion)
                   5.4 Asia Pacific
                      5.4.1 Asia Pacific cervical cancer diagnostic market estimates and forecasts, by test type 2013 - 2024 (USD Billion)
                      5.4.2 Japan
                            5.4.2.1 Japan cervical cancer diagnostic market estimates and forecasts, by test type 2013 - 2024 (USD Billion)
                      5.4.3 China
                            5.4.3.1 China cervical cancer diagnostic market estimates and forecasts, by test type 2013 - 2024 (USD Billion)
                   5.5 Latin America
                      5.5.1 Latin America cervical cancer diagnostic market estimates and forecasts, by test type 2013 - 2024 (USD Billion)
                      5.5.2 Brazil
                            5.5.2.1 Brazil cervical cancer diagnostic market estimates and forecasts, by test type 2013 - 2024 (USD Billion)
                      5.5.3 Mexico
                            5.5.3.1 Mexico cervical cancer diagnostic market estimates and forecasts, by test type 2013 - 2024 (USD Billion)
                   5.6 MEA
                      5.6.1 MEA cervical cancer diagnostic market estimates and forecasts, by test type 2013 - 2024 (USD Billion)
                      5.6.2 South Africa
                            5.6.2.1 South Africa cervical cancer diagnostic market estimates and forecasts, by test type 2013 - 2024 (USD Billion)
Chapter 6 Competitive Landscape
                   6.1 Strategy Framework
                   6.2 Market Participation Categorization
                   6.3 Company Profiles
                      6.3.1 Abbott Molecular
                            6.3.1.1 Company overview
                            6.3.1.2 Financial performance
                            6.3.1.3 Product benchmarking
                            6.3.1.4 Strategic initiatives
                      6.3.2 F. Hoffmann-La Roche Ltd
                            6.3.2.1 Company overview
                            6.3.2.2 Financial performance
                            6.3.2.3 Product benchmarking
                            6.3.2.4 Strategic initiatives
                      6.3.3 QIAGEN
                            6.3.3.1 Company overview
                            6.3.3.2 Financial performance
                            6.3.3.3 Product benchmarking
                            6.3.3.4 Strategic initiatives
                      6.3.4 Quest Diagnostics, Inc.
                            6.3.4.1 Company overview
                            6.3.4.2 Financial performance
                            6.3.4.3 Product benchmarking
                            6.3.4.4 Strategic initiatives
                      6.3.5 Hologic, Inc.
                            6.3.5.1 Company overview
                            6.3.5.2 Financial performance
                            6.3.5.3 Product benchmarking
                            6.3.5.4 Strategic initiatives
                      6.3.6 Arbor Vita Corporation
                            6.3.6.1 Company overview
                            6.3.6.2 Financial performance
                            6.3.6.3 Product benchmarking
                            6.3.6.4 Strategic initiatives
                      6.3.7 OncoHealth Corporation
                            6.3.7.1 Company overview
                            6.3.7.2 Financial performance
                            6.3.7.3 Product benchmarking
                            6.3.7.4 Strategic initiatives
                      6.3.8 Dell Guided Therapeutics, Inc.
                            6.3.8.1 Company overview
                            6.3.8.2 Financial performance
                            6.3.8.3 Product benchmarking
                            6.3.8.4 Strategic initiatives
                      6.3.9 CooperSurgical, Inc.
                            6.3.9.1 Company overview
                            6.3.9.2 Financial performance
                            6.3.9.3 Product benchmarking
                            6.3.9.4 Strategic initiatives
                      6.3.10 Becton, Dickinson and Company (BD)
                            6.3.10.1 Company overview
                            6.3.10.2 Financial performance
                            6.3.10.3 Product benchmarking
                            6.3.10.4 Strategic initiatives


List of Tables

TABLE 1 Global cervical cancer diagnostic market revenue, by test type, 2013 - 2024 (USD Billion)
TABLE 2 Global cervical cancer diagnostic market revenue, by region, 2013 - 2024 (USD Billion)
TABLE 3 North America cervical cancer diagnostic market, by test type, 2013 - 2024 (USD Billion)
TABLE 4 U.S. cervical cancer diagnostic market, by test type, 2013 - 2024 (USD Billion)
TABLE 5 Canada cervical cancer diagnostic market, by test type, 2013 - 2024 (USD Billion)
TABLE 6 Europe cervical cancer diagnostic market, by test type, 2013 - 2024 (USD Billion)
TABLE 7 Germany cervical cancer diagnostic market, by test type, 2013 - 2024 (USD Billion)
TABLE 8 UK cervical cancer diagnostic market, by test type, 2013 - 2024 (USD Billion)
TABLE 9 Asia Pacific cervical cancer diagnostic market, by test type, 2013 - 2024 (USD Billion)
TABLE 10 Japan cervical cancer diagnostic market, by test type, 2013 - 2024 (USD Billion)
TABLE 11 China cervical cancer diagnostic market, by test type, 2013 - 2024 (USD Billion)
TABLE 12 Latin America cervical cancer diagnostic market, by test type, 2013 - 2024 (USD Billion)
TABLE 13 Brazil cervical cancer diagnostic market, by test type, 2013 - 2024 (USD Billion)
TABLE 14 Mexico cervical cancer diagnostic market, by test type, 2013 - 2024 (USD Billion)
TABLE 15 MEA cervical cancer diagnostic market, by test type, 2013 - 2024 (USD Billion)
TABLE 16 South Africa cervical cancer diagnostic market, by test type, 2013 - 2024 (USD Billion)


List of Figures

FIG. 1 Market summary
FIG. 2 Market trends & outlook
FIG. 3 Market segmentation & scope
FIG. 4 Market driver relevance analysis (Current & future impact)
FIG. 5 Market restraint relevance analysis (Current & future impact)
FIG. 6 Penetration & growth prospect mapping
FIG. 7 SWOT Analysis, by factor (Political & legal, economic and technological)
FIG. 8 Porter’s Five Forces Analysis
FIG. 9 Cervical cancer diagnostic market: Test type outlook key takeaways
FIG. 10 Cervical cancer diagnostic market: Test type movement analysis
FIG. 11 Global Pap testing market estimates and forecasts, 2013 - 2024 (USD Billion)
FIG. 12 Global HPV testing market estimates and forecasts, 2013 - 2024 (USD Billion)
FIG. 13 Global colposcopy market estimates and forecasts, 2013 - 2024 (USD Billion)
FIG. 14 Global cervical biopsies market estimates and forecasts, 2013 - 2024 (USD Billion)
FIG. 15 Global cystoscopy market estimates and forecasts, 2013 - 2024 (USD Billion)
FIG. 16 Regional market place: Key takeaways
FIG. 17 Regional outlook, 2015 & 2024
FIG. 18 North America cervical cancer diagnostic market estimates and forecasts, by test type, 2013 - 2024(USD Billion)
FIG. 19 U.S. cervical cancer diagnostic market estimates and forecasts, by test type, 2013 - 2024(USD Billion)
FIG. 20 Canada cervical cancer diagnostic market estimates and forecasts, by test type, 2013 - 2024 (USD Billion)
FIG. 21 Europe cervical cancer diagnostic market estimates and forecasts,by test type, 2013 - 2024 (USD Billion)
FIG. 21 Germany cervical cancer diagnostic market estimates and forecasts,by test type, 2013 - 2024 (USD Billion)
FIG. 22 UK cervical cancer diagnostic market estimates and forecasts, by test type, 2013 - 2024 (USD Billion)
FIG. 23 Asia Pacific cervical cancer diagnostic market estimates and forecasts, by test type, 2013 - 2024 (USD Billion)
FIG. 24 Japan cervical cancer diagnostic market estimates and forecasts, by test type, 2013 - 2024 (USD Billion)
FIG. 25 China cervical cancer diagnostic market estimates and forecasts, by test type, 2013 - 2024 (USD Billion)
FIG. 26 Latin America cervical cancer diagnostic market estimates and forecasts, by test type, 2013 - 2024 (USD Billion)
FIG. 27 Brazil cervical cancer diagnostic market estimates and forecasts, by test type, 2013 - 2024 (USD Billion)
FIG. 28 Mexico cervical cancer diagnostic market estimates and forecasts, by test type, 2013 - 2024 (USD Billion)
FIG. 29 MEA cervical cancer diagnostic market estimates and forecasts, by test type 2013 -2024 (USD Billion)
FIG. 30 South Africa cervical cancer diagnostic market estimates and forecasts, by test type, 2013 - 2024 (USD Billion)
FIG. 31 Strategy framework

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.